Anouve is developing a blood-based
Anouve is developing a blood-based
screening method for colorectal cancer
screening method for colorectal cancer
Samples collected from clinical trials will be used to determine the performance characteristics of the test.
Blood tests will be part of our colorectal cancer screening portfolio to cover the 600 million people in China who need to be screened for colorectal cancer.
